The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Sorafenib in locally advanced or metastatic patients with radioactive iodine-refractory differentiated thyroid cancer: The phase III DECISION trial.
Marcia S. Brose
Consultant or Advisory Role - Bayer; Onyx
Honoraria - Bayer
Research Funding - Bayer
Christopher Nutting
No relevant relationships to disclose
Barbara Jarzab
Consultant or Advisory Role - AstraZeneca
Rossella Elisei
Consultant or Advisory Role - Bayer
Honoraria - Bayer
Salvatore Siena
Consultant or Advisory Role - Amgen; Bayer; Celgene; Genomic Health; Roche; Sanofi
Lars Bastholt
Consultant or Advisory Role - AstraZeneca
Christelle de la Fouchardiere
No relevant relationships to disclose
Furio Pacini
Honoraria - Bayer
Research Funding - Bayer
Ralf Paschke
No relevant relationships to disclose
Young Kee Shong
No relevant relationships to disclose
Steven I. Sherman
Consultant or Advisory Role - AstraZeneca; Bayer; Eisai; Exelixis; Lilly; Novo Nordisk; Veracyte
Honoraria - AstraZeneca; Bayer; Eisai; Exelixis; Lilly; Novo Nordisk; Veracyte
Research Funding - Genzyme; Pfizer
Johannes WA Smit
Honoraria - Bayer
John Woojune Chung
Employment or Leadership Position - Bayer
Harald Siedentop
Employment or Leadership Position - Bayer
Stock Ownership - Bayer (B)
Istvan Molnar
Employment or Leadership Position - Bayer
Martin Schlumberger
Consultant or Advisory Role - AstraZeneca (U); Bayer (U); Eisai (U); Exelixis (U); Genzyme (U)
Honoraria - AstraZeneca; Genzyme
Research Funding - Genzyme